Media stories about R1 RCM (NASDAQ:RCM) have trended somewhat positive recently, according to Accern Sentiment Analysis. The research firm identifies positive and negative press coverage by monitoring more than twenty million blog and news sources. Accern ranks coverage of public companies on a scale of negative one to one, with scores closest to one being the most favorable. R1 RCM earned a news sentiment score of 0.20 on Accern’s scale. Accern also gave news coverage about the financial services provider an impact score of 44.9304281009611 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the company’s share price in the near future.

A number of research firms recently weighed in on RCM. Robert W. Baird upgraded R1 RCM from a “neutral” rating to an “outperform” rating and set a $9.00 price target for the company in a research report on Monday, April 9th. ValuEngine upgraded R1 RCM from a “hold” rating to a “buy” rating in a research report on Monday, April 2nd. Cantor Fitzgerald began coverage on R1 RCM in a research report on Tuesday, March 13th. They set an “overweight” rating and a $9.00 price objective for the company. Cowen restated an “in-line” rating and set a $10.00 price objective (up from $5.00) on shares of R1 RCM in a research report on Monday, March 12th. Finally, BidaskClub upgraded R1 RCM from a “buy” rating to a “strong-buy” rating in a research report on Saturday, March 10th. Two investment analysts have rated the stock with a hold rating, three have issued a buy rating and one has given a strong buy rating to the company. The company has an average rating of “Buy” and an average target price of $8.00.

How to Become a New Pot Stock Millionaire

Shares of NASDAQ RCM opened at $7.24 on Tuesday. R1 RCM has a one year low of $3.05 and a one year high of $7.99. The stock has a market cap of $757.60, a price-to-earnings ratio of -16.45 and a beta of -0.75.

R1 RCM (NASDAQ:RCM) last announced its quarterly earnings data on Friday, March 9th. The financial services provider reported ($0.08) EPS for the quarter, missing the Zacks’ consensus estimate of ($0.01) by ($0.07). R1 RCM had a negative return on equity of 31.68% and a negative net margin of 13.07%. The business had revenue of $140.30 million for the quarter, compared to analyst estimates of $131.20 million. equities analysts predict that R1 RCM will post -0.15 earnings per share for the current fiscal year.

WARNING: “R1 RCM (RCM) Receives News Impact Rating of 0.20” was originally posted by Daily Political and is the sole property of of Daily Political. If you are viewing this news story on another site, it was illegally copied and republished in violation of U.S. and international copyright & trademark legislation. The original version of this news story can be accessed at

About R1 RCM

R1 RCM Inc is a provider of revenue cycle management (RCM) and physician advisory services (PAS) to healthcare providers. The Company is engaged in providing management services of revenue cycle operations for the United States-based hospitals and other medical services providers. Its primary service offering consists of end-to-end RCM, which the Company deploys through a co-managed relationship or an operating partner relationship.

Insider Buying and Selling by Quarter for R1 RCM (NASDAQ:RCM)

Receive News & Ratings for R1 RCM Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for R1 RCM and related companies with's FREE daily email newsletter.